Oncology Central

To what extent will 5-aminolevulinic acid change the face of malignant glioma surgery?

0

Glioma surgery is an essential part of glioma management; however, fully achieving the goal of surgery has been uncommon. The goal of surgery is ‘maximal safe resection’ with the accepted target for maximal being complete resection of the contrast-enhancing tumor. This ideal result was obtained in less than 30% of cases in centers of excellence until a few years ago. The development of fluorescence-guided surgery using 5-aminolevulinic acid has initiated a radical change.

To view restricted content, please:
Share:

Leave A Comment